Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 105kWORD 23k
20 November 2018
Answer given by Mr Moedas on behalf of the European Commission
Question reference: E-004770/2018

The participation of Israeli entities in Horizon 2020 is governed by the Agreement between the EU and the State of Israel on the participation of the State of Israel in the Union programme ‘Horizon 2020 — the framework Programme for Research and Innovation (2014-2020)’. The agreement makes the participation of Israeli entities subject to Horizon 2020 rules, which includes the applicability of the Commission Notice Nr. 2013/C-205/05EU(1) (the Guidelines).

Ahava-Dead Sea Laboratories Ltd (AHAVA) participates in one Horizon 2020 project(2). Activities carried out by AHAVA in the frame of this project may not take place in the territories occupied by Israel since June 1967.

AHAVA does have operations in the settlement Mitzpeh Shalem, located in Occupied Territories as well as in the Kibbutz Ein Gedi, located within Israel’s pre-1967 borders. In accordance with the Guidelines, AHAVA was required to declare its commitment to comply with the relevant eligibility criteria upon application for funding.

Verifications made during the course of PEPTICAPS, including through visits by consortium partners to AHAVA, have not questioned AHAVA’s compliance with the Guidelines. The Commission will endeavour to perform reinforced monitoring of the project in its assessment of the final reporting period, which is due on 4 December 2018.

Should it be found that the applicable eligibility requirements have not been complied with the Commission may take appropriate actions.

(1)‘Guidelines of 2013 on the eligibility of Israeli entities and their activities in the territories occupied by Israel since June 1967 for grants, prizes and financial instruments funded by the EU from 2014 onwards’.
(2)PEPTICAPS: Design of polyPEPTIdes diblock copolymers as emulsifiers to produce safe, controlled and reliable novel stimuli-responsive nanoCAPSules for skin care applications — http://www.pepticaps.eu/

Last updated: 20 November 2018Legal notice